Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Carcinoma, Pancreatic Ductal | 6 | 2024 | 1727 | 1.090 |
Why?
|
Pancreatic Neoplasms | 8 | 2024 | 5367 | 1.020 |
Why?
|
Tumor Microenvironment | 5 | 2024 | 3868 | 0.950 |
Why?
|
Nerve Tissue | 1 | 2021 | 78 | 0.730 |
Why?
|
Neoplastic Cells, Circulating | 2 | 2018 | 943 | 0.710 |
Why?
|
Lipid Bilayers | 5 | 2009 | 383 | 0.710 |
Why?
|
Neoplasms | 9 | 2024 | 22131 | 0.620 |
Why?
|
Neurosciences | 1 | 2022 | 367 | 0.570 |
Why?
|
Meningioma | 4 | 2019 | 1215 | 0.520 |
Why?
|
Nucleosomes | 3 | 2016 | 487 | 0.480 |
Why?
|
Prognosis | 18 | 2024 | 29600 | 0.460 |
Why?
|
Prostatectomy | 2 | 2018 | 1824 | 0.440 |
Why?
|
Meningeal Neoplasms | 3 | 2019 | 1245 | 0.430 |
Why?
|
DNA, Neoplasm | 1 | 2018 | 1743 | 0.420 |
Why?
|
Esophagus | 1 | 2018 | 1031 | 0.400 |
Why?
|
Gene Expression Profiling | 3 | 2024 | 9417 | 0.380 |
Why?
|
Postoperative Care | 1 | 2018 | 1467 | 0.380 |
Why?
|
Neuroblastoma | 1 | 2019 | 1248 | 0.370 |
Why?
|
DNA Copy Number Variations | 2 | 2022 | 2020 | 0.360 |
Why?
|
Radiotherapy, Adjuvant | 5 | 2020 | 1784 | 0.350 |
Why?
|
Alkanes | 1 | 2008 | 41 | 0.310 |
Why?
|
Esophageal Neoplasms | 1 | 2018 | 1653 | 0.300 |
Why?
|
Computing Methodologies | 1 | 2007 | 17 | 0.300 |
Why?
|
Oils | 1 | 2007 | 56 | 0.290 |
Why?
|
Cell Communication | 2 | 2024 | 1654 | 0.280 |
Why?
|
Immunotherapy | 2 | 2021 | 4642 | 0.270 |
Why?
|
Prostatic Neoplasms | 2 | 2018 | 11106 | 0.250 |
Why?
|
Water | 3 | 2008 | 1409 | 0.250 |
Why?
|
Histones | 2 | 2016 | 2577 | 0.240 |
Why?
|
Chemokine CCL5 | 1 | 2024 | 214 | 0.230 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 2 | 2022 | 5319 | 0.220 |
Why?
|
Oropharyngeal Neoplasms | 2 | 2019 | 491 | 0.210 |
Why?
|
Papillomavirus Infections | 3 | 2020 | 1611 | 0.210 |
Why?
|
Lung Neoplasms | 4 | 2022 | 13382 | 0.210 |
Why?
|
Papillomaviridae | 2 | 2019 | 1117 | 0.210 |
Why?
|
Salvage Therapy | 3 | 2018 | 1263 | 0.210 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3088 | 0.200 |
Why?
|
Radiation Injuries | 2 | 2020 | 1189 | 0.200 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3209 | 0.200 |
Why?
|
Neoadjuvant Therapy | 2 | 2024 | 2827 | 0.200 |
Why?
|
Gene Expression Regulation, Neoplastic | 3 | 2024 | 8542 | 0.200 |
Why?
|
Lymphopenia | 1 | 2024 | 281 | 0.200 |
Why?
|
Combined Modality Therapy | 6 | 2019 | 8516 | 0.190 |
Why?
|
Nervous System Physiological Phenomena | 1 | 2022 | 114 | 0.190 |
Why?
|
T Cell Transcription Factor 1 | 1 | 2021 | 72 | 0.190 |
Why?
|
Humans | 46 | 2024 | 760617 | 0.190 |
Why?
|
Hepatocyte Nuclear Factor 1-alpha | 1 | 2021 | 174 | 0.180 |
Why?
|
Lipids | 3 | 2008 | 3332 | 0.180 |
Why?
|
Disease-Free Survival | 4 | 2019 | 6807 | 0.170 |
Why?
|
Pandemics | 1 | 2020 | 8645 | 0.170 |
Why?
|
Adenosine Triphosphatases | 2 | 2014 | 835 | 0.160 |
Why?
|
Cholangiocarcinoma | 1 | 2024 | 552 | 0.160 |
Why?
|
Neoplasm Metastasis | 3 | 2019 | 4910 | 0.160 |
Why?
|
Bile Duct Neoplasms | 1 | 2024 | 605 | 0.160 |
Why?
|
Drug Resistance, Neoplasm | 2 | 2024 | 5304 | 0.150 |
Why?
|
Radiation Oncology | 1 | 2024 | 563 | 0.150 |
Why?
|
Immune Evasion | 1 | 2021 | 363 | 0.150 |
Why?
|
Receptors, Virus | 1 | 2021 | 639 | 0.150 |
Why?
|
CD8-Positive T-Lymphocytes | 2 | 2021 | 4571 | 0.150 |
Why?
|
Cranial Irradiation | 1 | 2020 | 390 | 0.140 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2015 | 9277 | 0.140 |
Why?
|
Hematopoietic Stem Cell Transplantation | 5 | 2017 | 5672 | 0.140 |
Why?
|
Transforming Growth Factor beta | 1 | 2024 | 1963 | 0.140 |
Why?
|
Single-Cell Analysis | 2 | 2024 | 2447 | 0.130 |
Why?
|
Saccharomyces cerevisiae | 3 | 2016 | 2674 | 0.130 |
Why?
|
TNF-Related Apoptosis-Inducing Ligand | 1 | 2016 | 192 | 0.130 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 1 | 2021 | 1088 | 0.130 |
Why?
|
Neoplasm Invasiveness | 2 | 2021 | 3593 | 0.120 |
Why?
|
BK Virus | 1 | 2016 | 123 | 0.120 |
Why?
|
Mutation | 5 | 2022 | 30016 | 0.120 |
Why?
|
Saccharomyces cerevisiae Proteins | 2 | 2016 | 1836 | 0.120 |
Why?
|
Computer Simulation | 2 | 2008 | 6233 | 0.120 |
Why?
|
Thorax | 1 | 2018 | 555 | 0.120 |
Why?
|
Radiotherapy, Conformal | 1 | 2018 | 548 | 0.120 |
Why?
|
Neoplasm Staging | 6 | 2020 | 11116 | 0.120 |
Why?
|
Interleukin-6 | 1 | 2024 | 3206 | 0.120 |
Why?
|
Spodoptera | 1 | 2014 | 141 | 0.120 |
Why?
|
Lymphoma, T-Cell, Peripheral | 1 | 2015 | 125 | 0.110 |
Why?
|
Polyomavirus Infections | 1 | 2016 | 194 | 0.110 |
Why?
|
Ion Channels | 2 | 2009 | 1039 | 0.110 |
Why?
|
Treatment Outcome | 11 | 2020 | 64568 | 0.110 |
Why?
|
Cell Line, Tumor | 3 | 2024 | 16967 | 0.110 |
Why?
|
Antigens, Neoplasm | 1 | 2021 | 1985 | 0.110 |
Why?
|
Tumor Burden | 1 | 2019 | 1892 | 0.110 |
Why?
|
Sex Distribution | 1 | 2018 | 2278 | 0.110 |
Why?
|
Tumor Virus Infections | 1 | 2016 | 438 | 0.110 |
Why?
|
Opportunistic Infections | 1 | 2016 | 376 | 0.110 |
Why?
|
ROC Curve | 1 | 2021 | 3575 | 0.110 |
Why?
|
Allosteric Regulation | 1 | 2014 | 427 | 0.100 |
Why?
|
Male | 21 | 2024 | 360358 | 0.100 |
Why?
|
Capsid Proteins | 1 | 2016 | 464 | 0.100 |
Why?
|
Medical Oncology | 1 | 2024 | 2317 | 0.100 |
Why?
|
Transplantation, Homologous | 3 | 2017 | 4804 | 0.100 |
Why?
|
Nanoparticles | 1 | 2024 | 1957 | 0.100 |
Why?
|
Hemolysin Proteins | 2 | 2009 | 113 | 0.100 |
Why?
|
Epithelial-Mesenchymal Transition | 1 | 2016 | 737 | 0.100 |
Why?
|
Survival Rate | 3 | 2024 | 12719 | 0.100 |
Why?
|
Aged | 15 | 2024 | 169042 | 0.090 |
Why?
|
Angiopoietins | 1 | 2011 | 85 | 0.090 |
Why?
|
Metaphase | 1 | 2010 | 145 | 0.090 |
Why?
|
Transcription Factors | 3 | 2016 | 12116 | 0.090 |
Why?
|
Propensity Score | 1 | 2018 | 1911 | 0.090 |
Why?
|
Dendritic Cells | 1 | 2021 | 2722 | 0.090 |
Why?
|
Retrospective Studies | 12 | 2024 | 80566 | 0.090 |
Why?
|
SEER Program | 3 | 2020 | 1450 | 0.090 |
Why?
|
Lymph Nodes | 1 | 2021 | 3461 | 0.090 |
Why?
|
Female | 21 | 2024 | 392148 | 0.080 |
Why?
|
Middle Aged | 16 | 2024 | 220584 | 0.080 |
Why?
|
World Health Organization | 1 | 2015 | 1321 | 0.080 |
Why?
|
Brain Neoplasms | 3 | 2020 | 9026 | 0.080 |
Why?
|
DNA, Viral | 1 | 2016 | 2195 | 0.080 |
Why?
|
Chromosomal Proteins, Non-Histone | 1 | 2014 | 725 | 0.080 |
Why?
|
Patient Care Team | 1 | 2020 | 2515 | 0.080 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2021 | 3634 | 0.080 |
Why?
|
Computational Biology | 1 | 2021 | 3509 | 0.080 |
Why?
|
Clinical Trials as Topic | 2 | 2022 | 7995 | 0.080 |
Why?
|
Head and Neck Neoplasms | 2 | 2020 | 2894 | 0.080 |
Why?
|
Karyotyping | 1 | 2010 | 1171 | 0.080 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2018 | 2425 | 0.080 |
Why?
|
Stem Cells | 1 | 2021 | 3516 | 0.080 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2019 | 2917 | 0.080 |
Why?
|
Potassium Channel Blockers | 1 | 2008 | 161 | 0.080 |
Why?
|
Neurosurgical Procedures | 2 | 2017 | 2067 | 0.080 |
Why?
|
Health Status Disparities | 1 | 2020 | 1846 | 0.080 |
Why?
|
Porins | 1 | 2008 | 78 | 0.070 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 1 | 2018 | 1405 | 0.070 |
Why?
|
Hippocampus | 1 | 2020 | 3761 | 0.070 |
Why?
|
Solutions | 1 | 2008 | 412 | 0.070 |
Why?
|
Cell Cycle Proteins | 1 | 2019 | 3447 | 0.070 |
Why?
|
Protein Structure, Tertiary | 1 | 2014 | 3792 | 0.070 |
Why?
|
DNA-Binding Proteins | 2 | 2016 | 9586 | 0.070 |
Why?
|
Prostate-Specific Antigen | 1 | 2016 | 2465 | 0.070 |
Why?
|
Graft vs Host Disease | 2 | 2017 | 3028 | 0.070 |
Why?
|
Aneuploidy | 1 | 2010 | 552 | 0.070 |
Why?
|
Kaplan-Meier Estimate | 4 | 2020 | 6474 | 0.070 |
Why?
|
Singapore | 2 | 2018 | 292 | 0.070 |
Why?
|
Bacterial Toxins | 2 | 2009 | 925 | 0.070 |
Why?
|
Animals | 8 | 2024 | 168201 | 0.070 |
Why?
|
Bone Neoplasms | 1 | 2019 | 2527 | 0.070 |
Why?
|
Boronic Acids | 1 | 2010 | 915 | 0.070 |
Why?
|
Proportional Hazards Models | 1 | 2021 | 12447 | 0.070 |
Why?
|
Aged, 80 and over | 7 | 2024 | 58894 | 0.060 |
Why?
|
Potassium Channels | 1 | 2008 | 537 | 0.060 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2017 | 1639 | 0.060 |
Why?
|
Risk Factors | 5 | 2020 | 74115 | 0.060 |
Why?
|
Bacterial Outer Membrane Proteins | 1 | 2008 | 404 | 0.060 |
Why?
|
Chemokine CCL8 | 1 | 2024 | 17 | 0.060 |
Why?
|
Antineoplastic Agents | 3 | 2024 | 13635 | 0.060 |
Why?
|
Pancreas | 2 | 2023 | 1690 | 0.060 |
Why?
|
Pyrazines | 1 | 2010 | 1202 | 0.060 |
Why?
|
Myelodysplastic Syndromes | 1 | 2014 | 1394 | 0.060 |
Why?
|
Signal Transduction | 2 | 2024 | 23416 | 0.060 |
Why?
|
Sex Factors | 1 | 2018 | 10548 | 0.060 |
Why?
|
Graft Rejection | 1 | 2017 | 4446 | 0.060 |
Why?
|
Nanotechnology | 1 | 2009 | 713 | 0.050 |
Why?
|
DNA | 2 | 2014 | 7196 | 0.050 |
Why?
|
Darkness | 1 | 2023 | 158 | 0.050 |
Why?
|
Chemokine CXCL1 | 1 | 2023 | 101 | 0.050 |
Why?
|
Incidence | 2 | 2018 | 21337 | 0.050 |
Why?
|
Microfluidic Analytical Techniques | 1 | 2009 | 799 | 0.050 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2017 | 2249 | 0.050 |
Why?
|
Adult | 10 | 2024 | 220969 | 0.050 |
Why?
|
Receptors, CCR5 | 1 | 2024 | 486 | 0.050 |
Why?
|
Chromatin | 1 | 2014 | 2955 | 0.050 |
Why?
|
Treatment Failure | 2 | 2019 | 2635 | 0.050 |
Why?
|
Fluorescence Resonance Energy Transfer | 2 | 2016 | 420 | 0.050 |
Why?
|
Follow-Up Studies | 5 | 2024 | 39063 | 0.050 |
Why?
|
Diagnostic Imaging | 1 | 2015 | 3527 | 0.050 |
Why?
|
Receptors, CCR6 | 1 | 2021 | 74 | 0.050 |
Why?
|
Receptors, Tumor Necrosis Factor, Type II | 1 | 2023 | 344 | 0.050 |
Why?
|
Escherichia coli Proteins | 1 | 2008 | 1064 | 0.050 |
Why?
|
Radiotherapy Planning, Computer-Assisted | 2 | 2020 | 1655 | 0.050 |
Why?
|
Biology | 1 | 2023 | 290 | 0.050 |
Why?
|
Delayed-Action Preparations | 1 | 2024 | 962 | 0.040 |
Why?
|
Mesenchymal Stem Cells | 1 | 2011 | 1642 | 0.040 |
Why?
|
Mice | 6 | 2024 | 81368 | 0.040 |
Why?
|
Prospective Studies | 3 | 2019 | 54360 | 0.040 |
Why?
|
Actuarial Analysis | 1 | 2019 | 372 | 0.040 |
Why?
|
Drug Carriers | 1 | 2024 | 706 | 0.040 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2018 | 11736 | 0.040 |
Why?
|
Disease Progression | 3 | 2023 | 13495 | 0.040 |
Why?
|
Oligopeptides | 1 | 2024 | 1185 | 0.040 |
Why?
|
Hematopoietic Stem Cells | 1 | 2011 | 3394 | 0.040 |
Why?
|
Oropharynx | 1 | 2018 | 138 | 0.040 |
Why?
|
Radiotherapy | 1 | 2024 | 1497 | 0.040 |
Why?
|
Mitotic Index | 1 | 2017 | 162 | 0.040 |
Why?
|
Cohort Studies | 2 | 2018 | 41457 | 0.040 |
Why?
|
Infant | 1 | 2019 | 36152 | 0.040 |
Why?
|
Nasopharyngeal Neoplasms | 1 | 2019 | 290 | 0.030 |
Why?
|
Standard of Care | 1 | 2020 | 551 | 0.030 |
Why?
|
Child, Preschool | 1 | 2019 | 42188 | 0.030 |
Why?
|
Survival Analysis | 2 | 2019 | 10073 | 0.030 |
Why?
|
Cystitis | 1 | 2016 | 95 | 0.030 |
Why?
|
Pancreatectomy | 1 | 2020 | 811 | 0.030 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2023 | 1745 | 0.030 |
Why?
|
Necrosis | 1 | 2019 | 1610 | 0.030 |
Why?
|
Ki-67 Antigen | 1 | 2017 | 627 | 0.030 |
Why?
|
Peptides | 2 | 2021 | 4354 | 0.030 |
Why?
|
Epitopes | 1 | 2021 | 2501 | 0.030 |
Why?
|
Asia, Southeastern | 1 | 2014 | 114 | 0.030 |
Why?
|
Kidney Function Tests | 1 | 2017 | 678 | 0.030 |
Why?
|
Models, Biological | 2 | 2008 | 9461 | 0.030 |
Why?
|
Postoperative Complications | 1 | 2017 | 15612 | 0.030 |
Why?
|
Membrane Proteins | 2 | 2008 | 7847 | 0.030 |
Why?
|
Probability | 1 | 2019 | 2475 | 0.030 |
Why?
|
Recurrence | 2 | 2017 | 8426 | 0.030 |
Why?
|
Skull Base Neoplasms | 1 | 2017 | 270 | 0.030 |
Why?
|
United States | 2 | 2020 | 72272 | 0.030 |
Why?
|
Graft Survival | 2 | 2017 | 3820 | 0.030 |
Why?
|
T-Lymphocyte Subsets | 1 | 2021 | 1798 | 0.030 |
Why?
|
Base Pairing | 1 | 2013 | 140 | 0.030 |
Why?
|
Adolescent | 5 | 2019 | 88234 | 0.030 |
Why?
|
Radiotherapy Dosage | 1 | 2019 | 2897 | 0.030 |
Why?
|
DNA Repair | 1 | 2022 | 2043 | 0.030 |
Why?
|
Disease Susceptibility | 1 | 2019 | 1788 | 0.030 |
Why?
|
Brain | 1 | 2019 | 27101 | 0.030 |
Why?
|
Multiple Myeloma | 1 | 2010 | 5146 | 0.030 |
Why?
|
Receptors, Antigen, T-Cell | 1 | 2021 | 2546 | 0.030 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2020 | 3514 | 0.020 |
Why?
|
Hydrolysis | 1 | 2013 | 661 | 0.020 |
Why?
|
Watchful Waiting | 1 | 2015 | 491 | 0.020 |
Why?
|
Predictive Value of Tests | 2 | 2018 | 15251 | 0.020 |
Why?
|
Social Class | 1 | 2020 | 1992 | 0.020 |
Why?
|
Young Adult | 4 | 2019 | 59179 | 0.020 |
Why?
|
Immunocompromised Host | 1 | 2016 | 858 | 0.020 |
Why?
|
Neutrophils | 1 | 2023 | 3763 | 0.020 |
Why?
|
Cost of Illness | 1 | 2020 | 1935 | 0.020 |
Why?
|
Remission Induction | 1 | 2015 | 2391 | 0.020 |
Why?
|
Amino Acid Sequence | 1 | 2021 | 13441 | 0.020 |
Why?
|
Electrochemistry | 1 | 2009 | 145 | 0.020 |
Why?
|
Vaccination | 1 | 2021 | 3370 | 0.020 |
Why?
|
Population Surveillance | 1 | 2019 | 2595 | 0.020 |
Why?
|
Microchip Analytical Procedures | 1 | 2008 | 29 | 0.020 |
Why?
|
Liver Neoplasms | 1 | 2024 | 4308 | 0.020 |
Why?
|
Antigens, CD34 | 1 | 2011 | 658 | 0.020 |
Why?
|
Chromatin Assembly and Disassembly | 1 | 2013 | 634 | 0.020 |
Why?
|
Glomerular Filtration Rate | 1 | 2017 | 2178 | 0.020 |
Why?
|
Cell-Free System | 1 | 2008 | 339 | 0.020 |
Why?
|
Radiosurgery | 1 | 2017 | 1339 | 0.020 |
Why?
|
Algorithms | 1 | 2007 | 14018 | 0.020 |
Why?
|
Electrodes | 1 | 2009 | 610 | 0.020 |
Why?
|
Membranes, Artificial | 1 | 2008 | 366 | 0.020 |
Why?
|
Viral Load | 1 | 2016 | 3325 | 0.020 |
Why?
|
Polymerase Chain Reaction | 1 | 2016 | 6074 | 0.020 |
Why?
|
Genomics | 1 | 2022 | 5822 | 0.020 |
Why?
|
Adenosine Triphosphate | 1 | 2013 | 1988 | 0.020 |
Why?
|
Risk Assessment | 2 | 2019 | 23972 | 0.020 |
Why?
|
Early Detection of Cancer | 1 | 2020 | 3196 | 0.020 |
Why?
|
Mesenchymal Stem Cell Transplantation | 1 | 2011 | 499 | 0.020 |
Why?
|
Transplantation, Autologous | 1 | 2010 | 2112 | 0.020 |
Why?
|
Disease Models, Animal | 1 | 2024 | 18221 | 0.020 |
Why?
|
Translocation, Genetic | 1 | 2010 | 1392 | 0.010 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2010 | 2509 | 0.010 |
Why?
|
Fetal Blood | 1 | 2011 | 1347 | 0.010 |
Why?
|
Hemorrhage | 1 | 2016 | 3418 | 0.010 |
Why?
|
Phenotype | 1 | 2021 | 16571 | 0.010 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2008 | 1333 | 0.010 |
Why?
|
Inflammation | 1 | 2023 | 10760 | 0.010 |
Why?
|
Cell Culture Techniques | 1 | 2011 | 1662 | 0.010 |
Why?
|
Glycoproteins | 1 | 2011 | 2200 | 0.010 |
Why?
|
Immunosuppressive Agents | 1 | 2016 | 4174 | 0.010 |
Why?
|
Transplantation, Heterologous | 1 | 2011 | 2382 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2017 | 10432 | 0.010 |
Why?
|
Time Factors | 2 | 2016 | 39913 | 0.010 |
Why?
|
Antigens, CD | 1 | 2011 | 3998 | 0.010 |
Why?
|
Bone Marrow | 1 | 2010 | 2909 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2020 | 17878 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2011 | 18937 | 0.010 |
Why?
|
T-Lymphocytes | 1 | 2011 | 10175 | 0.010 |
Why?
|